Exploring a Breast Cancer Early Screening Model Based on cfDNA

CompletedOBSERVATIONAL
Enrollment

839

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

December 13, 2023

Study Completion Date

October 31, 2024

Conditions
Breast CancerBreast FibroadenomaBreast Hypoplasia
Interventions
GENETIC

cfDNA sequencing

Multi-omics sequencing of cfDNA in peripheral venous blood.

Trial Locations (8)

233000

The First Affiliated Hospital of Bengbu Medical University, Bengbu

310000

Affiliated Hangzhou First People's Hospital ,Westlake University School of Medicine, Hangzhou

Sir Run Run Shaw Hospital Affiliated With Zhejiang University School of Medicine, Hangzhou

Wenhui Community Health Service center, Gongshu district, Hangzhou city, Hangzhou

Women's Hospital School Of Medicine Zhejiang University, Hangzhou

Zhejiang Provincial Hospital Of Traditional Chinese Medicine, Hangzhou

310009

Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

315046

Ningbo Medical Center Lihuili Hospital, Ningbo

All Listed Sponsors
collaborator

OmixScience Institute

UNKNOWN

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER